2 5 F e b r u a r y 2 0 1 6 | V O L 5 3 0 | N a T u r e | 4 8 1 LeTTer Because autism spectrum disorders are neurodevelopmental disorders and patients typically display symptoms before the age of three 1 , one of the key questions in autism research is whether the pathology is reversible in adults. Here we investigate the developmental requirement of Shank3 in mice, a prominent monogenic autism gene that is estimated to contribute to approximately 1% of all autism spectrum disorder cases 2-6 . SHANK3 is a postsynaptic scaffold protein that regulates synaptic development, function and plasticity by orchestrating the assembly of postsynaptic density macromolecular signalling complex 7-9 . Disruptions of the Shank3 gene in mouse models have resulted in synaptic defects and autistic-like behaviours including anxiety, social interaction deficits, and repetitive behaviour 10-13 . We generated a novel Shank3 conditional knock-in mouse model, and show that re-expression of the Shank3 gene in adult mice led to improvements in synaptic protein composition, spine density and neural function in the striatum. We also provide behavioural evidence that certain behavioural abnormalities including social interaction deficit and repetitive grooming behaviour could be rescued, while anxiety and motor coordination deficit could not be recovered in adulthood. Together, these results reveal the profound effect of post-developmental activation of Shank3 expression on neural function, and demonstrate a certain degree of continued plasticity in the adult diseased brain.
Because autism spectrum disorders are neurodevelopmental disorders and patients typically display symptoms before the age of three 1 , one of the key questions in autism research is whether the pathology is reversible in adults. Here we investigate the developmental requirement of Shank3 in mice, a prominent monogenic autism gene that is estimated to contribute to approximately 1% of all autism spectrum disorder cases 2-6 . SHANK3 is a postsynaptic scaffold protein that regulates synaptic development, function and plasticity by orchestrating the assembly of postsynaptic density macromolecular signalling complex [7] [8] [9] . Disruptions of the Shank3 gene in mouse models have resulted in synaptic defects and autistic-like behaviours including anxiety, social interaction deficits, and repetitive behaviour [10] [11] [12] [13] . We generated a novel Shank3 conditional knock-in mouse model, and show that re-expression of the Shank3 gene in adult mice led to improvements in synaptic protein composition, spine density and neural function in the striatum. We also provide behavioural evidence that certain behavioural abnormalities including social interaction deficit and repetitive grooming behaviour could be rescued, while anxiety and motor coordination deficit could not be recovered in adulthood. Together, these results reveal the profound effect of post-developmental activation of Shank3 expression on neural function, and demonstrate a certain degree of continued plasticity in the adult diseased brain.
SHANK3 (also known as ProSAP2) protein is a major scaffolding protein at the excitatory synapse, coordinating the recruitment of many postsynaptic signalling molecules 14, 15 . Previous work has shown that germline deletion of Shank3 in mice disrupts the protein composition at the postsynaptic density (PSD), reduces neurotransmission efficiency and leads to autistic-like behaviour [10] [11] [12] [13] .
To address whether adult reversal of physiological and behavioural abnormalities in Shank3 mutant mice is possible, we adopted a genetic method that allows for inducible Shank3 expression. Because Shank3 duplication is linked to attention deficit hyperactivity disorder and bipolar disorder 5, 6, 16 , it is crucial to keep Shank3 expression within its physiological concentrations to avoid potential confounds. Thus, we generated a novel Shank3 conditional knock-in mouse by using the Cre-dependent genetic switch (FLEx) strategy 17 , which enables the conditional manipulation of the Shank3 gene at its endogenous genomic locus.
We genetically targeted the PDZ domain owing to its role in assembling the scaffold complex in the PSD 14, 15 (Fig. 1a and Extended Data Fig. 1 ). In the absence of Cre, the Shank3 fx/fx mice function as Shank3 knockout (KO) mice, and result in the deletion of most major isoforms of SHANK3 including the putative α, β and γ bands (Fig. 1b ). Similar to abnormalities previously reported on Shank3 knockout mice [10] [11] [12] [13] , these Shank3 fx/fx mice showed significant deficits in exploratory behaviour ( Fig. 1c) , anxiety ( Fig. 1e ) and motor coordination (Fig. 1d) , and displayed open wound lesions that suggested repetitive grooming behaviour 12, 18 . In addition, they showed impaired neurotransmission in the dorsal striatum ( Fig. 1f, g) . These novel Shank3 fx/fx mice thus recapitulate autistic-like phenotypes, enabling us to investigate the possibility of reversing those deficits in adulthood.
To achieve temporal control of Shank3 expression, we crossed the Shank3 fx/fx mice to an inducible CAGGS-CreER mouse line 19 that activates global Cre function after tamoxifen treatment (Extended Data Fig. 1d ). When the Shank3 fx/fx :CreER +/− mice reached 2-4.5 months, we used oral gavage to deliver tamoxifen to ensure efficient Cre-mediated gene restoration ( Fig. 2a show a decreased pop spike amplitude in extracellular field recordings in the striatum. g, Normal relationship of stimulation intensity to the negative peak 1 (NP1) amplitude (action potential component), suggesting unaltered presynaptic function; insets show representative traces. *P < 0.05, **P < 0.01, ***P < 0.001 (two-tailed t-test (c, left, e) and two-way repeated measures analysis of variance (ANOVA) with Bonferroni posthoc test (c, right, d, f, g)). Data are mean ± s.e.m. (all behaviour data from n = 6 WT and n = 7 KO mice; electrophysiology data from n = 9 slices; 3 mice per genotype). See Supplementary Fig. 1 for gel source data.
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treated with tamoxifen (wild type, WT), Shank3 fx/fx :CreER +/− mice treated with tamoxifen (TM), and Shank3 fx/fx :CreER +/− mice treated with corn oil vehicle (KO). Synaptosomal preparations showed that tamoxifen treatment restored the expression of most major SHANK3 isoforms, including the α and β isoforms, to the wild-type level at synapses ( Fig. 2b) .
Because SHANK3 is the only SHANK protein family member highly enriched in the striatum, a region strongly implicated in certain behaviours associated with autism 12,18 , mechanistic characterizations were primarily carried out on striatal neurons. We found that the synaptic concentrations of scaffold proteins SAPAP3, Homer1b/c and glutamate receptor subunits NR2A, NR2B and GluA2 were significantly reduced in KO striatal synaptosomal preparations. However, in the TM condition, the synaptic levels of these postsynaptic proteins were significantly increased compared to those in the KO mice, reaching comparable levels to the WT (Fig. 2c ). This molecular alteration shows for the first time, to our knowledge, that restoring Shank3 expression in the adult brain can efficiently recruit major scaffolding and signalling proteins to the synapse and assemble the PSD protein network even after the developmental period.
To investigate whether there were functional changes parallel to molecular repair at synapses, we examined striatal physiology. As expected, the KO mice showed significantly reduced field population spikes. However, the reduced field responses were rescued to WT levels in the TM condition ( Fig. 2d, e ). We then performed wholecell recordings and found that the KO mice had reduced miniature excitatory postsynaptic current (mEPSC) frequency compared to WT mice. Notably, mEPSC frequency was rescued in the TM condition to comparable levels of the WT group ( Fig. 2f ). We also measured the paired-pulse ratio, the AMPAR/NMDAR ratio (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor/N-methyl-daspartate receptor) (Extended Data Figs 2 and 3), and NR2B (also known as GRIN2B)/total NMDAR ratio (Extended Data Fig. 2c ). We found no differences across genotypes. Overall, these results suggest that a primary defect of striatal physiology in KO mice is the reduced mEPSC frequency, and this defect can be improved by restoring SHANK3 expression in adulthood.
Previous studies have shown that Shank3 manipulation can lead to significant changes in the total spine density 6, 12 . It is, however, unclear whether post-developmental Shank3 expression can also affect spine structure. To address this, we used systemic viral injection to sparsely label neurons with green fluorescdent protein (GFP) in the WT, KO 
and TM mice and analysed their dendritic spines in the dorsal striatum. Similar to our previous report on Shank3B (a Shank3 isoform) KO mice 12 , we observed a significant reduction of medium spiny neuron (MSN) spine density in the KO compared to WT mice. Surprisingly, the total spine density was significantly increased in the TM-treated mice compared to the KO mice ( Fig. 2g ). To our knowledge, this is the first indication that the ability of Shank3 to promote spine formation or maintenance is not restricted to any developmentally critical period, highlighting the continued structural plasticity in the adult striatum. Interestingly, the spine density in the TM condition is significantly higher than that of the WT. One possibility for this phenomenon is that adult Shank3 expression induces dendritic spines that may not be pruned and regulated by the same processes that occur in development.
We next tested how adult SHANK3 expression may affect behavioural abnormalities. Because striatal defects have been strongly linked to repetitive and compulsive behaviours 20, 21 , and Shank3 KO mice show signs of overgrooming 12 , we filmed WT, TM and KO mice after treatment, and quantified their grooming time. The results indicated that while there was a significant increase in the percentage of time spent grooming in the KO mice compared to WT mice, TM mice exhibited a significantly reduced grooming time ( Fig. 3a, b ). In addition, during the tamoxifen treatment, we noticed that some Shank3 fx/fx :CreER +/− mice that had initially developed lesions began to heal and regrow their lost fur, providing further support that the repetitive/excessive grooming phenotype is reversible in the Shank3 fx/fx mice.
One of the defining features of autism is the impairment in social interaction. Thus, we used a modified three-chamber assay to probe voluntary social interaction 12, 13, 22 . After habituating to the three-chamber box, the test mice were given a choice of interacting with either a novel object or a stranger mouse. We found that although WT mice demonstrated a strong preference for the stranger mouse compared with the novel object, KO mice displayed no such preference ( Fig. 3c, d) .
Notably, we found that TM mice behaved similarly to the WT controls in that they showed a strong preference for the stranger mouse in both the duration and frequency of the interaction (Fig. 3c, d) . These data show that, similar to the repetitive grooming behaviour, the social interaction deficit can also be rescued in adulthood. Currently, the neurobiological mechanisms of social deficits of autism spectrum disorder are not well understood. Although ventral striatum has been associated with social interaction 23 , we did not observe differences in the measurements of mEPSCs, the AMPAR/NMDAR ratio or the paired-pulse ratio in the ventral striatum/nucleus accumbens across genotypes (Extended Data Fig. 4 ).
Encouraged by the rescue of repetitive grooming and social deficits, we ran a range of other tests to assess the extent of behavioural rescue. In contrast to the social and grooming behaviours, adult Shank3 re-expression has minimal effect on reduced locomotion, anxiety-like behaviour and motor coordination deficits ( Fig. 4) . In the open-field test, TM mice showed no significant difference from the KO mice in exploratory behaviour ( Fig. 4a ) and anxiety-like behaviour including rearing time and rearing frequency ( Fig. 4b ). This result was further corroborated by our observations from the elevated zero maze test (Fig. 4c ). In addition, we found no significant recovery in the motor coordination deficit (Fig. 4d ).
Because the cortex and cerebellum have been linked to anxiety and motor coordination, we assessed the mechanistic changes in these brain regions 24, 25 . In both regions, SHANK3 expression was restored to the WT level in TM mice (Extended Data Figs 5 and 6). However, we found minimal differences across the genotypes (Extended Data Figs 5-7) . Thus, the circuit mechanisms of anxiety and motor coordination deficits in the Shank3 KO mice may involve other brain regions or could be the collective consequence of connectivity deficits across many brain regions.
To address whether the lack of rescue in these behaviour phenotypes is indeed due to missing SHANK3 expression during development, we crossed Shank3 fx/fx mice to β-actin-Cre mice, enabling germline restoration of Shank3. The germline rescue mice showed no significant differences in striatal physiology (Extended Data Figs 4 and 8), exploratory behaviour ( Fig. 4e ), anxiety ( Fig. 4f , g) or motor coordination ( Fig. 4h ) compared to their wild-type littermates, indicating that restoring Shank3 expression at the germ-cell stage can restore all behavioural phenotypes. Together, these data strongly suggest that there are certain developmental defects that are irreversible by adult re-expression of Shank3.
To test whether there is a developmental window for rescuing anxiety and motor deficits, we treated postnatal day (P) 20-21 mice with tamoxifen to induce Shank3 expression efficiently (Extended Data Fig. 9a ), and assayed their behaviours in adulthood (Extended Data Figs 9 and 10). As previously reported 26 , we observed that the treatment of young mice with tamoxifen leads to some toxicity including reduced body weights in the wild-type mice, and affected their motor coordination compared to the KO mice fed with corn oil (Extended Data Fig. 10d ). However, even with the TM toxicity, we found that on the rotarod, the developmentally treated TM mice performed significantly better than their KO counterparts (Extended Data Fig. 10a, b) . The P20-P21-treated TM mice also showed significantly reduced anxiety on the elevated zero maze compared to the KO mice (Extended Data Fig. 9f ). Overall, these behavioural results show that earlier intervention Letter reSeArCH yields more behavioural improvement than adult treatment, further supporting the developmental origin of the behavioural abnormalities that are irreversible in adults.
We have shown that in the adult mouse brain, Shank3 expression can increase dendritic spine density, restore the PSD protein composition, and improve striatal neurotransmission. Although adult gene rescue characterizations have been performed on other autism genes 27, 28 , this is the first report, to our knowledge, to show selective rescue in specifically autism-related behavioural phenotypes. Notably, we also demonstrated that the behavioural deficits that are irreversible in the adult can be improved by early postnatal intervention. Our results highlight the unique behavioural effect of SHANK3 expression after development, and underscore the surprising extent of continued neural plasticity in the adult brain.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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Generation of Shank3 conditional knock-in (fx/fx) mice. The Shank3 fx/fx targeting vector was designed by inverting the PDZ domain (exons [13] [14] [15] [16] and flanking it with the FLEx cassette, which is composed of one pair of loxP sites staggered with one pair of lox2722 sites. Shank3 fx/fx conditional knock-in mice were generated by homologous recombination in R1 embryonic stem cells and implanting the correctly targeted cells into C57 blastocysts using standard procedures. Correct locus insertion of the targeting construct into the genomic DNA was determined by PCR genotyping using two primers End_F (5′-GGCAGACTCCACACAGTTCCTG-3′) and LoxR (5′-GTATCCTATACGAAGTTATTCCGGGTCGAC-3′). Subsequent mouse genotyping was determined by PCR of mouse tail or ear DNA using three primers. For the WT allele, primer FuncF2 (5′-CGTTTGACACACATAAGCACC-3′) and primer FuncFlipR4 (5′-CTCCACCTAGCTGAATTTCCC-3′) were used to produce a band of 340 base pairs (bp). For the knockout (Fx) allele, primer FuncF2 (5′-CGTTTGACACACATAAGCACC-3′) and primer Gen_Flx_R1 (5′-GCTGACATCACATTGCTGCC-3′) were used to produce a band of 481 bp. For the rescue allele, primer FuncF2 (5′-CGTTTGACACACATAAGCACC-3′) and primer FuncFlipR4 (5′-CTCCACCTAGCTGAATTTCCC-3′) were used to produce a band of 408 bp.
Chimaeric males were crossed to C57BL/6J females from Jackson Labs. The F 1 hybrids were crossed with C57BL/6J β-actin Flp to remove the neomycin cassette. All progeny were bred onto the pure C57BL/6J (Jackson Labs) for at least two generations before being bred onto a mixed background with 129S1/SvlmJ (Jackson Labs). Heterozygotes were initially bred with heterozygotes to produce experimental animals. All germline Shank3 fx/fx (KO) and germline rescue (GR) mice along with their respective wild-type littermates were produced by breeding heterozygotes with heterozygotes. For the adult Shank3 rescue experiments, the Shank3 conditional knock-in line was crossed with CAGGS-CreER 19 . To produce enough animals for all necessary experiments, breeding strategy was switched to heterozygotes crossed with homozygotes and homozygotes crossed with homozygotes for all conditions (Shank3 fx/+ :CreER +/− bred with Shank3 fx/fx :CreER −/− ; Shank3 fx/fx :CreER +/− bred with Shank3 fx/fx :CreER −/− ; Shank3 +/+ :CreER +/− bred with Shank3 +/+ :CreER −/− ; Shank3 +/− :CreER +/− bred with Shank3 +/+ :CreER −/− ). It should be noted that all animals in the rescue condition were produced from the same litters as the animals in the knockout condition. The animals were randomly assigned to different conditions. No computerized randomization program was used.
Animals were housed by genotype at a constant 23 °C in a 12-h light/dark cycle (lights on at 07:00, lights off at 19:00) with ad libitum food and water. Rescue treatment, that is tamoxifen feeding, was initiated on mice at 2-4.5 months. All electrophysiological and behavioural experiments were done at least 6 weeks after treatment in adult mice with the experimenter being blinded to the genotypes. Only age-matched male mice were used for behavioural assays. All experimental procedures were inspected and approved by the MIT Committee on Animal Care. Open-field test. An automated Omnitech Digiscan apparatus (AccuScan Instruments) was used to assess spontaneous locomotion as previously described 21 . Anxiety-like behaviours were assessed with the following parameters: time spent rearing and frequency of rearing. Locomotion was evaluated by the total distance travelled. The first 30 min were evaluated for all parameters. Statistical analysis was done using one-way ANOVA with Bonferroni multiple comparison tests. Elevated zero maze test. An elevated zero maze was illuminated such that the open arm was lit by 60 Lx, and the dark arm was lit by 10-20 Lx. Animals were habituated with 10-20 Lx for at least 1 h before the test. The animal was introduced into the closed arm and allowed to explore the maze freely for 5 min, and this was filmed. An observer blinded to the genotype performed analysis using the automated tracking software Noldus Ethovision. Anxiety-like behaviour was assessed as the percentage of time spent by the animal in the open arm during the 5-min interval. Statistical analysis was done using one-way ANOVA with Bonferroni multiple comparison tests. Rotarod test. Animals were placed on a rotarod apparatus (Med Associates) that accelerates 4-40 r.p.m. for 5 min. Each animal was tested for three trials with 1-2 h between trials in a single day. All trials were filmed. Latency to fall was manually analysed for each trial using Noldus Observer software by an observer blinded to genotypes. The change in the latency to fall over the course of three trails indicates the quality of motor coordination. Statistical analysis was done using two-way repeated measures ANOVA with Bonferroni post-hoc tests. Grooming. Animals were individually placed into a new cage and allowed to habituate. Grooming behaviour was filmed for 2 h from 19:00 to 21:00 with red light (2 Lx ). An observer blinded to the genotype manually quantified grooming behaviour using Noldus Observer. All instances of face-wiping, scratching/rubbing of head and ears, and full-body grooming were counted as grooming behaviour. Statistical analysis was done using one-way ANOVA with Bonferroni multiple comparison tests.
Social interaction test.
A modified version of the three-chamber social interaction assay was used as previously described 12, 13, 22 . Only age-matched males were used for all tests. S129 males were used as stranger mice and were habituated to the test chamber for three sessions (20 min each), 1 or 2 days before the behavioural assay. On the day of the test, both test and stranger animals were habituated to the test room for at least 1 h before the start of the assay. The left and right chambers of the three-chamber apparatus were both lit by 4-6 Lx during the test session. Each test animal was first placed into the centre chamber with open access to both the left and right chamber, each of which contained an empty wired cup placed upside down. This allowed the animal to habituate to not only the social apparatus, but also to the cups that will eventually contain the stranger mice. After 15 min of habituation, the test animal was moved back to the centre chamber briefly before the next session. During the social phase, an age-matched stranger mouse was placed randomly into one of the two side chambers while a novel object was placed into the other side chamber. The test animal was allowed to explore the social apparatus freely and demonstrate whether it prefers to interact with the novel object or novel mouse. This social phase was also for 15 min. The placement of the stranger mouse and the object was alternated between test mice to eliminate any confounds due to chamber bias. Time spent by the test animal in close proximity (~5 cm) to the cup containing either the stranger or the object was calculated. Analysis was done by an observer blinded to the genotype on Noldus Ethovision. One-way ANOVA with Bonferroni post-hoc test was used for statistical analysis. Tamoxifen preparation and feeding. Tamoxifen (Sigma, T5648) was dissolved in corn oil at 20 mg ml −1 by vortexing. Freshly prepared tamoxifen was protected from light by aluminium foil and kept for 2-3 days at room temperature. Animal feeding needles from Harvard Apparatus (52-4025) were used for oral gavage. To avoid toxicity of tamoxifen, the following dosages were used for adult animals: mice at 17-21 g body weight were fed 5 mg day −1 ; mice at 22-25 g body weight were fed 6 mg day −1 ; mice at 26-29 g body weight were fed 7 mg day −1 ; mice at 30-35 g body weight were fed 8 mg day −1 .
The adult animals were fed for 5 consecutive days followed by 2 weeks of rest. The animals were then fed for 5 more consecutive days followed by another 2 weeks of rest. Corn oil was used as a control. The mice fed with tamoxifen and with corn oil were housed separately to avoid contamination.
For induction of SHANK3 expression in P20-P21 animals, mice that weighed 7-9 g received 0.1 ml tamoxifen or corn oil per day for 2-3 consecutive days. Mice that weighed 10-12 g received 0.15 ml tamoxifen or coil per day for 2-3 consecutive days. Western blot. PSD and synaptosomal fractions of the striatum, cortex and cerebellum were prepared as previously described 21 . Purified fractions were separated on SDS-PAGE and quantified using Odyssey Licor. β-Actin and tubulin were used as loading controls. Specific primary antibody for SAPAP3 was prepared as previously described 21 . Commercial antibodies used include SHANK3 (Santa Cruz, SC-30193), GluR1 (Millipore, MAB2263), GluR2 (Neuromab, 75-002), NR1 (BD Biosciences, 556308), NR2A (Millipore, 07-632), NR2B (Millipore, 05-920), Homer1 (Chemicon, AB5877, Synaptic Systems, 160022), Homer3 (Synaptic Systems, 160303), mGLUR5 (Abcam, ab76316), CaMKIIa (Millipore, 05-532), SHANK1 (Synaptic Systems, 162002), SHANK2 (Cell Signaling, 12218S), β-actin (Sigma, A5441) and tubulin (Sigma, T5168). Statistical analysis was done using two-tailed Student's t-tests. Dendritic spine analysis. Age-matched male mice from WT (n = 5), KO (n = 4, 1 had to be euthanized owing to lesion development) and TM (n = 5) conditions at 6-12 months old were used. The pAAV-hSYN1-EGFP-P2A-EGFPf-WPRE-HGHpA construct was cloned and sent for commercial viral packaging by Upenn Viral Core with serotype 2/9. Farnesylated GFP (GFPf) was previously shown to target the membrane 29 . To achieve sparse labelling, ~8-30 μl of this virus with titre of 4.04 × 10 13 genome copies (GC) ml −1 was injected through the retro-orbital route into each mouse. Three weeks after viral injection, the mice were transcardially perfused with 4% paraformaldehyde and sectioned into 200-μm slices. Immunohistochemistry was performed by staining the slices with an anti-GFP antibody (Invitrogen, A11122) for 48 h and 24 h of secondary antibody incubation. The stained slices were then surrounded by a 240-μm depth spacer (Electron Microscopy Sciences) and mounted with Vectashield Mounting Media.
Confocal images were taken with a ×60 objective of the dorsal striatum. Spine count on intact neurons began 30-40 μm away from the soma and was extended for 10-60 μm from the origin. Spine density was analysed automatically by Neuron Studio. All virus injections, imaging and software analysis were done with the experimenter blinded to the mouse genotypes. Statistical analysis was done using one-way ANOVA, Newman-Keuls post-hoc test. Electrophysiology slices, dorsal and ventral striatum. Acute striatal slices were prepared from 3-7-month-old age-matched mice. Animals were anaesthetized by avertin intraperitoneal injection (tribromoethanol, 20 mg ml −1 , 0.5 mg g −1 body weight) and transcardially perfused with ice-cold oxygenated NMDG-based Letter reSeArCH cutting aCSF solution (mM): 92 N-methyl-d-glucamine (NMDG), 2.5 KCl, 1.20 NaH 4 PO 4 , 30 NaHCO 3 , 20 HEPES, 25 glucose, 2 thiourea, 5 Na-ascorbate, 3 Na-pyruvate, 0.5 CaCl 2 and 10 MgSO 4 (~300 mOsm, 7.2-7.4 pH). After decapitation, brains were removed for sectioning in the same ice-cold cutting aCSF using a Vibratome 1200S (Leica Microsystems). For all dorsal striatal recordings, 300-μm coronal slices were prepared, unless otherwise stated (Extended Data Fig. 3 ). For all nucleus accumbens (NAc) core recordings, 300-μm parasagittal slices were prepared and NAc core was identified by the presence of anterior commissure. Slices were recovered in the same cutting aCSF solution at 32 °C for 12 min and transferred to room-temperature carbogenated regular aCSF (mM): 119 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 24 NaHCO 3 , 12.5 glucose, 2 MgSO 4 .7H 2 O and 2 CaCl 2 .2H 2 O (~300 mOsm, 7.2-7.4 pH). Slices were allowed to recover at least ≥ 1 h and transferred to a recording chamber (RC-27L, Warner Instruments) before recordings. Stimulations were performed using a platinum iridium concentric bipolar electrode (CBAPC75, FHC). For dorsolateral striatum coronal slices, electrode was placed at the corpus callosum to mainly stimulate corticostriatal axons. For dorsolateral striatum parasagittal slices, stimulating electrode was placed at the cortex between layer V and VI. For ventral striatum parasagittal slices, electrode was placed dorsally to the anterior commissure at the border between NAc core and the cortex. Afferents were stimulated with 0.1 ms stimulation step (Isoflex, AMPI) delivered at 0.05 Hz frequency (unless otherwise stated). Slices were visualized under IR-DIC (infrared-differential interference contrast) using a BX-51WI microscope (Olympus). All slice preparations, recordings and data analysis were performed with experimenter blinded to the genotypes. Medial prefrontal cortex. Acute brain slices were prepared from 3-7-month-old mice as follows. In brief, mice were deeply anaesthetized by intraperitoneal injection of avertin solution (20 mg ml −1 , 0.5 mg g −1 body weight) and then transcardially perfused with 20 ml of carbogenated (95% O 2 , 5% CO 2 ) ice-cold cutting solution with the composition (in mM): 105 NMDG, 105 HCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 26 NaHCO 3 , 25 glucose, 10 MgSO 4 , 0.5 CaCl 2 , 1 l-ascorbic acid, 3 sodium pyruvate and 2 thiourea (pH 7.4, with osmolarity of 300-310 mOsm). The brains were rapidly removed and placed in ice-cold and oxygenated cutting solution. Coronal slices (300 μm) were sliced using Leica VT1200S (Leica Microsystems) and then transferred to recovery chamber at 32 °C with carbogenated cutting solution for 8 min, followed by transferring to holding chamber containing aCSF that contained (mM): 119 NaCl, 2.3 KCl, 1.0 NaH 2 PO 4 , 26 NaHCO 3 , 11 glucose, 1.3 MgSO 4 and 2.5 CaCl 2 (pH was adjusted to 7.4 with HCl, with osmolarity of 300-310 mOsm) at room temperature. Slices were allowed to recover for at least 2 h in holding chamber before recording and used for experiment typically between 3 and 7 h after slicing. Layer 5 pyramidal cells with a prominent apical dendrite were visually identified with a microscope equipped with IR-DIC optics (BX-51WI, Olympus) mainly by location, shape and pClampex online membrane test parameters. Extracellular field recordings. Slices were prepared from a daily group of mice containing all the three genotypes/treatments on randomized order, and recordings were obtained at room temperature with carbogenated regular aCSF (~2 ml min −1 rate). Borosilicate glass recording microelectrodes (King Precision Glass) were pulled on a P-97 horizontal puller (Sutter Instruments) and backfilled with 2 M NaCl. Recording electrode was placed ~400 μm away from stimulating electrode and field population-spike was evoked by a 0.1 ms stimulation step (Isoflex, AMPI) delivered at 0.05 Hz frequency. Input-output functions were generated through consecutive rounds from 0.1-1.0 mA in 0.1 mA increments (triplicate measurements per stimulation intensity). Three components were resolved in the recording traces: stimulation artefact, negative peak 1 (NP1, presynaptic fibre volley) and field population spike. Amplitude for each component was determined by the average peak amplitude from triplicated measurements per stimulation intensity. Data were amplified using a MultiClamp 700B and sampled at 10 kHz using a Digidata 1440A acquisition system. Analysis was performed blinded to genotype using pCLAMP 10 software (Axon Instruments/Molecular Devices). Whole-cell recordings. Borosilicate glass recording microelectrodes (King Precision Glass) were pulled on a P-97 horizontal puller (Sutter Instruments) and backfilled with CsGlu (mM): 110 CsOH, 110 d-gluconic acid, 15 KCl, 4 NaCl, 5 TEA-Cl, 20 HEPES, 0.2 EGTA, 5 lidocaine N-ethyl chloride, 4 MgATP and 0.3 NaGTP. Internal pH was adjusted to ~7.3 with KOH and osmolarity adjusted to ~300 mOsm with K 2 SO 4 . Typical internal resistance was around 3-5 MΩ. MSNs were visually identified based on their shape, size and location under IR-DIC, using a BX-51WI microscope (Olympus). After seal rupture and internal equilibrium (5 min to allow proper dialysis of Cs + internal), cells were recorded with series-resistance values <20 MΩ (recording traces were excluded for data analysis if series resistance changed by >20%). All voltage clamp traces were recorded in the presence of 50 μM picrotoxin (Tocris) with theoretical liquid junction potential not corrected for. Signals were filtered at 2 kHz, digitized at 10 kHz and data acquired using a MultiClamp 700B amplifier and a Digidata 1440A. All analyses were performed blinded to the genotype. Grubb's test was used to remove single outliers. mEPSCs. Slices were perfused with room temperature carbogenated regular aCSF at a rate of approximately 2 ml min −1 . Voltage clamp traces were recorded at holding potential −70 mV in the presence of 50 μM picrotoxin (Tocris), 50 μM dl-AP5 (dl-2-amino-5-phosphonovaleric acid, Abcam) and 1 μM tetrodotoxin (Tocris). Analysis of mEPSCs was performed using pCLAMP10 (Axon Instruments, Molecular Devices) and Minianalysis software (Synaptosoft) by manually clicking of individual events. Paired-pulse ratios. Slices were perfused with carbogenated regular aCSF at ~30 °C, ~2 ml min −1 rate. Stimulus intensity was set to evoke 150-400 pA EPSCs at holding potential −70 mV. Two EPSCs (inter-stimulus interval of 50 ms) were evoked for 10 consecutive traces. The paired-pulse ratio was calculated by dividing the second EPSC peak amplitude by the first one. AMPAR/NMDAR ratios. Slices were perfused with carbogenated regular aCSF at ~30 °C, ~2 ml min −1 rate. Stimulus intensity was set to evoke 150-400 pA EPSCs at holding potential −70 mV. An average EPSC was obtained (~10 traces) at −70 mV and then at +40 mV. The AMPAR/NMDAR ratio was calculated as the ratio of the average EPSC peak amplitude at −70 mV (AMPAR EPSC) to the average amplitude of the EPSC recorded at +40 mV, 50 ms after afferent stimulation. For pharmacologically isolated AMPAR/NMDAR ratios, dual-component evoked EPSCs at +40 mV was recorded before and after dl-AP5 bath application (50 μM, Abcam). NMDAR EPSC was obtained by digitally subtracting the average EPSC amplitude after dl-AP5 application (AMPAR EPSC). For NR2B/total NMDAR ratio, dual-component evoked EPSC at +40 mV was recorded before and after ifenprodil bath application (3 μM, NR2B antagonist, Tocris) and ifenprodil blockable fraction was defined as NR2B EPSCs. dl-AP5 (50 μM) was then applied to block all NMDARs for measuring total NMDAR EPSCs. The fraction of NR2B containing NMDAR EPSCs is presented as the percentage of the total NMDAR EPSCs (NR2B/total NMDAR ratio = ifenprodil sensitive current divided by dl-AP5 sensitive current). Statistical analyses. All statistical analyses were performed using Prism (GraphPad Software). All data sets were analysed using D' Agostino-Pearson omnibus test and Shapiro-Wilk test for normality. Data sets with normal distributions were analysed for significance using either unpaired Student's two-tailed t-test or ANOVA measures with multiple comparison post-hoc test, using *P < 0.05, **P < 0.01, ***P < 0.001; all data presented as mean ± s.e.m. Data sets with non-normal distributions were analysed using Kruskal-Wallis test with adjustments for multiple comparisons. On the basis of previously published SHANK3 models [10] [11] [12] [13] , we chose similar sample sizes for all experiments performed. All behaviour test results for the tamoxifen-treated cohorts are the combination of at least two different large animal cohorts that showed the same results. All electrophysiological, biochemical and morphological data were obtained by counterbalancing experimental conditions with controls. Further details on particular statistical analyses can be found on the respective figures/results section for each data set. 
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Extended Data Figure 2 | Additional measurements of dorsal striatum synaptic function in TM rescue. a, Representative traces (left) and bar graph (right) for the AMPAR/NMDAR ratio in WT, KO and TM groups (n = 30 WT, n = 33 KO and n = 33 TM MSNs). AMPAR/NMDAR ratio calculated as the ratio of the EPSC peak amplitude at −70 mV (AMPAR EPSC) to the amplitude of the EPSC recorded at +40 mV, 50 ms after afferent stimulation. b, Representative traces (left) and bar graph (right) for pharmacologically isolated AMPAR/NMDAR ratio (n = 20 WT, n = 20 KO and n = 23 TM MSNs). Dual-component evoked EPSC at +40 mV recorded before and after AP5 bath application. c, Representative traces (left) and bar graph (right) for the NR2B/NMDAR ratio in WT, KO and TM groups (n = 16 WT, n = 16 KO and n = 22 TM MSNs). Dualcomponent evoked EPSC at +40 mV recorded before and after ifenprodil bath application. N.S., not significant (Kruskal-Wallis test, with Dunn's multiple comparison test (a), one-way ANOVA with Bonferroni post-hoc test (b, c)). Data are mean ± s.e.m. c, Quantification of multiple synaptic proteins in the cerebellum of the adult treated mice. All data, n = 3 WT, n = 3 TM and n = 3 KO mice; each sample is from tissue taken from a single animal. Student's two-tailed unpaired t-test. Data are as mean ± s.e.m. See Supplementary Fig. 1 for gel source data.
